Decibel Therapeutics Inc.

08/26/2024 | Press release | Distributed by Public on 08/26/2024 00:20

Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadership in Respiratory Diseases